McKesson Corporation (BMV:MCK)

Market Cap	1.87T
Revenue (ttm)	7.12T
Net Income (ttm)	59.67B
Shares Out	n/a
EPS (ttm)	470.59
PE Ratio	31.39
Forward PE	20.54
Dividend	58.03 (0.43%)
Ex-Dividend Date	Sep 2, 2025

Volume	n/a
Average Volume	357
Open	13,653
Previous Close	13,653
Day's Range	13,653 - 13,653
52-Week Range	9,490 - 13,954
Beta	0.51
RSI	68.10
Earnings Date	Nov 5, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD